EE200000627A - Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks - Google Patents

Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks

Info

Publication number
EE200000627A
EE200000627A EEP200000627A EEP200000627A EE200000627A EE 200000627 A EE200000627 A EE 200000627A EE P200000627 A EEP200000627 A EE P200000627A EE P200000627 A EEP200000627 A EE P200000627A EE 200000627 A EE200000627 A EE 200000627A
Authority
EE
Estonia
Prior art keywords
investigation
bone
expression vector
kidney disease
promoter dna
Prior art date
Application number
EEP200000627A
Other languages
English (en)
Estonian (et)
Inventor
Kawai Shinji
Sugiura Takeyuki
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of EE200000627A publication Critical patent/EE200000627A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000627A 1998-04-30 1999-04-22 Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks EE200000627A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10120174A JPH11313675A (ja) 1998-04-30 1998-04-30 ヒトｂｍｐ−７プロモーターおよびこれを用いた骨関連物質の探索法
PCT/IB1999/000733 WO1999057293A1 (en) 1998-04-30 1999-04-22 Human bmp-7 promoter and method for exploring bone-related substance by using the same

Publications (1)

Publication Number Publication Date
EE200000627A true EE200000627A (et) 2002-02-15

Family

ID=14779761

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000627A EE200000627A (et) 1998-04-30 1999-04-22 Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks

Country Status (26)

Country Link
US (2) US6534268B1 (uk)
EP (1) EP1076713A1 (uk)
JP (1) JPH11313675A (uk)
KR (1) KR20010071193A (uk)
CN (1) CN1170941C (uk)
AP (1) AP1329A (uk)
AU (1) AU769124B2 (uk)
BG (1) BG64780B1 (uk)
BR (1) BR9910585A (uk)
CA (1) CA2326957A1 (uk)
EA (1) EA004509B1 (uk)
EE (1) EE200000627A (uk)
GE (1) GEP20033056B (uk)
HR (1) HRP20000736A2 (uk)
HU (1) HUP0102329A3 (uk)
ID (1) ID26704A (uk)
IL (1) IL139100A0 (uk)
NO (1) NO20005433L (uk)
NZ (1) NZ507625A (uk)
PL (1) PL343817A1 (uk)
SK (1) SK16082000A3 (uk)
TR (1) TR200003182T2 (uk)
UA (1) UA72212C2 (uk)
WO (1) WO1999057293A1 (uk)
YU (1) YU64900A (uk)
ZA (1) ZA200006080B (uk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20070015701A1 (en) * 2005-06-01 2007-01-18 Samuel Zalipsky Macromolecular conjugates of bone morphogenetic protein-7
WO2008045498A1 (en) * 2006-10-12 2008-04-17 Ethicon, Inc. Kidney-derived cells and methods of use in tissue repair and regeneration
WO2009139525A1 (en) * 2008-05-16 2009-11-19 Industry Foundation Of Chonnam National University An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
CA2799786A1 (en) 2010-06-09 2011-12-15 Semprus Biosciences Corp. Non-fouling, anti-microbial, anti-thrombogenic graft compositions
AU2011264834B2 (en) 2010-06-09 2015-03-12 Semprus Biosciences Corp. Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
WO2011156596A2 (en) 2010-06-09 2011-12-15 Semprus Biosciences Corp. Articles having non-fouling surfaces and processes for preparing the same including pretreatment of substrates
WO2012024489A2 (en) 2010-08-18 2012-02-23 Emory University Compounds and compositions for ossification and methods related thereto
US11179500B2 (en) 2011-02-24 2021-11-23 Emory University JAB1 inhibitory compositions for ossification and methods related thereto
EP2678050B1 (en) 2011-02-24 2020-10-14 Emory University Noggin blocking compositions for ossification and methods related thereto
CA2859195C (en) 2011-12-14 2016-09-27 Semprus Biosciences Corp. Imbibing process for contact lens surface modification
CA2858730C (en) 2011-12-14 2017-07-18 Semprus Biosciences Corp. Surface modified contact lenses
US9000063B2 (en) 2011-12-14 2015-04-07 Semprus Biosciences Corporation Multistep UV process to create surface modified contact lenses
US9120119B2 (en) 2011-12-14 2015-09-01 Semprus Biosciences Corporation Redox processes for contact lens modification
WO2013090790A1 (en) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants
WO2019005563A1 (en) * 2017-06-27 2019-01-03 St. Jude Children's Research Hospital METHODS ASSOCIATED WITH THE ACTIVATION OF THE SIGNALING PATHWAY OF BONE MORPHOGENETIC PROTEINS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
DK0429570T3 (da) 1989-03-28 1998-04-27 Genetics Inst Osteoinducerende præparater
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
WO1993003382A2 (en) * 1991-08-01 1993-02-18 Pharmaceutical Discovery Corporation Characterization of specific drug receptors with fluorescent ligands
CA2191583C (en) * 1994-06-07 2007-03-27 Engin Ozkaynak Methods and compositions for modulating morphogenic protein expression
US6083690A (en) * 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
EP0937145A1 (en) 1996-11-22 1999-08-25 Akzo Nobel N.V. Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
US5863790A (en) 1997-05-14 1999-01-26 Minnesota Mining And Manfacturing Company Biological sterility indicator
CA2291510A1 (en) * 1997-05-29 1998-12-03 Curis, Inc. Modulators of morphogen expression and methods of identifying the same

Also Published As

Publication number Publication date
AP1329A (en) 2004-11-22
AP2000001982A0 (en) 2000-12-31
HUP0102329A3 (en) 2006-03-28
NO20005433D0 (no) 2000-10-27
BR9910585A (pt) 2001-01-09
TR200003182T2 (tr) 2001-02-21
GEP20033056B (en) 2003-08-25
NO20005433L (no) 2000-10-27
EA200001130A1 (ru) 2001-04-23
AU769124B2 (en) 2004-01-15
CN1170941C (zh) 2004-10-13
UA72212C2 (en) 2005-02-15
HUP0102329A2 (hu) 2001-10-28
US20030040007A1 (en) 2003-02-27
US6534268B1 (en) 2003-03-18
WO1999057293A1 (en) 1999-11-11
JPH11313675A (ja) 1999-11-16
SK16082000A3 (sk) 2001-05-10
EA004509B1 (ru) 2004-04-29
IL139100A0 (en) 2001-11-25
ID26704A (id) 2001-02-01
CA2326957A1 (en) 1999-11-11
AU3163499A (en) 1999-11-23
HRP20000736A2 (en) 2001-10-31
NZ507625A (en) 2003-12-19
KR20010071193A (ko) 2001-07-28
EP1076713A1 (en) 2001-02-21
BG104883A (en) 2001-05-31
YU64900A (sh) 2003-10-31
ZA200006080B (en) 2001-10-29
CN1307643A (zh) 2001-08-08
BG64780B1 (bg) 2006-03-31
PL343817A1 (en) 2001-09-10

Similar Documents

Publication Publication Date Title
EE200000627A (et) Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks
AU2003284891A8 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
AU2002216273A1 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
DE69728408D1 (de) Nichtinvasive abbildung von biologischem gewebe
EP1233697A4 (en) NON-INVASIVE METHOD FOR CONTINUOUS DETERMINATION OF PHYSIOLOGICAL CHARACTERISTICS AND DEVICE THEREFOR
WO2003055443A3 (en) Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
DE69830087D1 (de) Gerät zur therapeutischen Kauterisation von vorbestimmten Volumen biologischen Gewebes
WO2001066596A3 (en) Human fgf-23 gene and gene expression products
WO2002022871A3 (en) Polymorphic bone morphogenetic protein 2
AU2002330215A1 (en) Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
WO2001057198A3 (en) Methods of generating protein expression arrays and the use thereof in rapid screening
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
BR9712767A (pt) Expressão especìfica para tecido de proteìna de retinoblastoma
EA200100544A1 (ru) Способ экспресс-диагностики физиологического состояния биологического объекта и устройство для его осуществления
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
AU2001233954A1 (en) Proteins, genes and their use for diagnosis and treatment of schizophrenia
EE200000631A (et) Inimese BMP-4 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudaine uurimiseks
WO2001083524A3 (en) Rna metabolism proteins
WO2002016587A3 (en) Microtubule-associated proteins and tubulins
WO2002034282A3 (en) Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis
WO2002040649A8 (en) Slo2 and slo4, novel potassium channel proteins from human brain
Astakhov et al. Methods of electron-vibrational time-resolution spectra simulation of complex molecules; Metody modelirovaniya ehlektronno-kolebatel'nykh spektrov slozhnykh molekul s vremennym razresheniem
AU2002222307A1 (en) Proteins, genes and their use for diagnosis and treatment of cardiac response

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner